Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
Back to team page

Dr. Richard Pye

Chief Financial Officer
Richard is an experienced corporate development and investor relations professional.

He previously worked for over 15 years at the AIM and Nasdaq listed biotechnology company, Summit Therapeutics. He held a variety of scientific and business roles as the company matured from being a University of Oxford spin-out into a global, late-stage clinical development organisation; most recently Richard held the position of Vice President of Corporate Affairs and Investor Relations. During his time with Summit, Richard gained strong cross border experience of the UK and US capital markets, investor relations, financial reporting, corporate development and strategy, and corporate governance for AIM and Nasdsq.

He holds a PhD in organic chemistry and was a Post Doctoral Research Associate at the University of Oxford prior to moving into the biotechnology industry.